These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 22988865)
1. Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease. Greggio E Biochem Soc Trans; 2012 Oct; 40(5):1058-62. PubMed ID: 22988865 [TBL] [Abstract][Full Text] [Related]
2. LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's disease. Xiong Y; Dawson VL; Dawson TM Biochem Soc Trans; 2012 Oct; 40(5):1074-9. PubMed ID: 22988868 [TBL] [Abstract][Full Text] [Related]
3. Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions. Drolet RE; Sanders JM; Kern JT J Neurogenet; 2011 Dec; 25(4):140-51. PubMed ID: 22077787 [TBL] [Abstract][Full Text] [Related]
4. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease. Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749 [TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of LRRK2: from kinase to substrate. Lobbestael E; Baekelandt V; Taymans JM Biochem Soc Trans; 2012 Oct; 40(5):1102-10. PubMed ID: 22988873 [TBL] [Abstract][Full Text] [Related]
6. Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression. Henry AG; Aghamohammadzadeh S; Samaroo H; Chen Y; Mou K; Needle E; Hirst WD Hum Mol Genet; 2015 Nov; 24(21):6013-28. PubMed ID: 26251043 [TBL] [Abstract][Full Text] [Related]
7. Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants. Li X; Tan YC; Poulose S; Olanow CW; Huang XY; Yue Z J Neurochem; 2007 Oct; 103(1):238-47. PubMed ID: 17623048 [TBL] [Abstract][Full Text] [Related]
8. Novel insights into the neurobiology underlying LRRK2-linked Parkinson's disease. Gómez-Suaga P; Fdez E; Fernández B; Martínez-Salvador M; Blanca Ramírez M; Madero-Pérez J; Rivero-Ríos P; Fuentes JM; Hilfiker S Neuropharmacology; 2014 Oct; 85():45-56. PubMed ID: 24863040 [TBL] [Abstract][Full Text] [Related]
9. Molecular biology changes associated with LRRK2 mutations in Parkinson's disease. Lu YW; Tan EK J Neurosci Res; 2008 Jul; 86(9):1895-901. PubMed ID: 18338801 [TBL] [Abstract][Full Text] [Related]
10. Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation. Luzón-Toro B; Rubio de la Torre E; Delgado A; Pérez-Tur J; Hilfiker S Hum Mol Genet; 2007 Sep; 16(17):2031-9. PubMed ID: 17584768 [TBL] [Abstract][Full Text] [Related]
11. Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease. Gandhi PN; Chen SG; Wilson-Delfosse AL J Neurosci Res; 2009 May; 87(6):1283-95. PubMed ID: 19025767 [TBL] [Abstract][Full Text] [Related]
12. The biology and pathobiology of LRRK2: implications for Parkinson's disease. Moore DJ Parkinsonism Relat Disord; 2008; 14 Suppl 2():S92-8. PubMed ID: 18602856 [TBL] [Abstract][Full Text] [Related]
13. [Advance of the study on LRRK2 gene in Parkinson's disease]. Zhang Y; Chen S Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):657-9. PubMed ID: 19065525 [TBL] [Abstract][Full Text] [Related]
14. LRRK2 in Parkinson's disease: protein domains and functional insights. Mata IF; Wedemeyer WJ; Farrer MJ; Taylor JP; Gallo KA Trends Neurosci; 2006 May; 29(5):286-93. PubMed ID: 16616379 [TBL] [Abstract][Full Text] [Related]
15. G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy. Yakhine-Diop SM; Bravo-San Pedro JM; Gómez-Sánchez R; Pizarro-Estrella E; Rodríguez-Arribas M; Climent V; Aiastui A; López de Munain A; Fuentes JM; González-Polo RA Toxicology; 2014 Oct; 324():1-9. PubMed ID: 25017139 [TBL] [Abstract][Full Text] [Related]
16. [Molecular basis of Parkinson's disease linked with mutations in the LRRK2 gene]. Pchelina SN; emel'ianov AK; Usenko TS Mol Biol (Mosk); 2014; 48(1):3-14. PubMed ID: 25842821 [TBL] [Abstract][Full Text] [Related]